NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Wednesday:
Merck & Co., up $6.23 to $131.75.
The drug developer received U.S. approval for a high blood pressure treatment.
Shockwave Medical Inc., up $6.54 to $322.61.
Johnson & Johnson is reportedly considering buying the medical device maker.
Cintas Corp., up $52.24 to $685.64.
The uniform rental company raised its earnings forecast for the year.
GameStop Corp., down $2.33 to $13.17.
The video game retailer's fourth-quarter earnings and revenue fell short of Wall Street forecasts.
MiMedx Group Inc., down 1 cent to $7.61.
The developer of biomaterials for wound care challenged a negative regulatory decision from the Food and Drug Administration.
NCino Inc., up $5.72 to $35.90.
The cloud-based software company beat analysts' fourth-quarter earnings forecasts.
Roivant Sciences Ltd., up 76 cents to $10.84.
The biopharmaceutical company is joining the S&P MidCap 400.
NovoCure Ltd., up $1.57 to $14.64.
The cancer treatment developer said a potential lung cancer therapy met a key research goal.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
